isopsa: interim clinical performance evaluation of a novel structure-based biomarker for pca
Published 3 years ago • 57 plays • Length 5:44Download video MP4
Download video MP3
Similar videos
-
2:09
isopsa: blood-based assay for improved detection of prostate cancer
-
7:09
transperineal prostate biopsies under local anesthesia
-
5:26
fti2018 -transrectal needle-based targeted treatment of pca
-
1:28
fiducial in a seminal vesicle recurrence of pca
-
31:23
clinical case - staging of high-risk pca
-
3:32
transrectal periprostatic block
-
4:40
targeted prostate biopsy using mri-us fusion
-
1:10:05
psma scans & pluvicto (lutetium-177) in 2022 | geoffrey johnson, md, phd | pcri conference 2022
-
1:14
prevent unneeded biopsies with isopsa
-
29:04
exosomes as a platform for clinical diagnostics
-
2:13
ask the expert: what makes the new psa test different than a traditional test?
-
1:29
mpmri is a paradigm shift in prostate cancer diagnostics
-
3:48
what is the 4kscore™ test by opko health?
-
30:52
webinar emerging evidence on psa in the diagnosis of prostate cancer
-
1:56
healthwatch: prevent unneeded biopsies with isopsa
-
26:35
cardiovascular considerations in pca patients treated with adt
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
4:02
precision medicine in prostate cancer
-
4:42
biparametric vs multiparametric prostate mri for the detection of pca in treatment‐naïve patients
-
0:41
psa tests -- why are they important?
-
1:47
prostate cancer diagnosis and tests